Download PDF
Semin Liver Dis 2014; 34(04): e1
DOI: 10.1055/s-0044-1786507
Erratum

Erratum: Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities

Sumera I Ilyas
1   Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
,
Mitesh J. Borad
2   Division of Hematology and Oncology, Mayo Clinic, Scottsdale, Arizona
,
Tushar Patel
3   Departments of Internal Medicine, Transplantation and Cancer Biology, Mayo Clinic, Jacksonville, Florida
,
Gregory J. Gores
1   Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
› Author Affiliations
› Further Information
    Permissions and Reprints

Correction to:

Cholangiocarcinoma: Molecular Pathways and Therapeutic OpportunitiesSemin Liver Dis 2014; 34(04): 456-464
DOI: 10.1055/s-0034-1394144

It has been brought to the publisher's attention that the name of the author “Sumera Rizvi” was incorrect in the online version of the above article in the Journal of Seminars in Liver Disease, published in Volume 34, Number 4 (DOI: 10.1055/s-0034-1394144). The name of the author has been corrected to reflect as “Sumera I Ilyas” in the version available online.



Publication History

Article published online:
17 April 2024

© 2024. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA